Suppr超能文献

干细胞疗法在ACL移植物再生中的应用。

Application of Stem Cell Therapy for ACL Graft Regeneration.

作者信息

Wang Canlong, Hu Yejun, Zhang Shichen, Ruan Dengfeng, Huang Zizhan, He Peiwen, Cai Honglu, Heng Boon Chin, Chen Xiao, Shen Weiliang

机构信息

Department of Orthopedic Surgery, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang 310009, China.

Orthopaedics Research Institute of Zhejiang University, Zhejiang, China.

出版信息

Stem Cells Int. 2021 Aug 2;2021:6641818. doi: 10.1155/2021/6641818. eCollection 2021.

Abstract

Graft regeneration after anterior cruciate ligament (ACL) reconstruction surgery is a complex three-stage process, which usually takes a long duration and often results in fibrous scar tissue formation that exerts a detrimental impact on the patients' prognosis. Hence, as a regeneration technique, stem cell transplantation has attracted increasing attention. Several different stem cell types have been utilized in animal experiments, and almost all of these have shown good capacity in improving tendon-bone regeneration. Various differentiation inducers have been widely applied together with stem cells to enhance specific lineage differentiation, such as recombinant gene transfection, growth factors, and biomaterials. Among the various different types of stem cells, bone marrow-derived mesenchymal stem cells (BMSCs) have been investigated the most, while ligament stem progenitor cells (LDSCs) have demonstrated the best potential in generating tendon/ligament lineage cells. In the clinic, 4 relevant completed trials have been reported, but only one trial with BMSCs showed improved outcomes, while 5 relevant trials are still in progress. This review describes the process of ACL graft regeneration after implantation and summarizes the current application of stem cells from bench to bedside, as well as discusses future perspectives in this field.

摘要

前交叉韧带(ACL)重建手术后的移植物再生是一个复杂的三阶段过程,通常持续时间较长,并且常常导致纤维瘢痕组织形成,这对患者的预后产生不利影响。因此,作为一种再生技术,干细胞移植已引起越来越多的关注。几种不同类型的干细胞已用于动物实验,并且几乎所有这些干细胞在改善腱骨再生方面都显示出良好的能力。各种分化诱导剂已与干细胞一起广泛应用,以增强特定谱系分化,例如重组基因转染、生长因子和生物材料。在各种不同类型的干细胞中,骨髓间充质干细胞(BMSCs)研究得最多,而韧带干祖细胞(LDSCs)在产生肌腱/韧带谱系细胞方面显示出最佳潜力。在临床上,已报道了4项相关的完成试验,但只有一项使用BMSCs的试验显示出改善的结果,同时还有5项相关试验正在进行中。本综述描述了植入后ACL移植物再生的过程,总结了干细胞从实验室到临床的当前应用,并讨论了该领域的未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d83/8352687/e1253ff5af30/SCI2021-6641818.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验